Advertisement







Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2009; 54:386-396, doi:10.1016/j.jacc.2009.02.078
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goodlin, S. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Goodlin, S. J.
Related Collections
Right arrowRelated Article

QUARTERLY FOCUS ISSUE: HEART FAILURE: STATE-OF-THE-ART PAPER

Palliative Care in Congestive Heart Failure

Sarah J. Goodlin, MD*

Patient-Centered Education and Research, Salt Lake City, Utah

Manuscript received October 5, 2008; revised manuscript received February 6, 2009, accepted February 9, 2009.

* Reprint requests and correspondence: Dr. Sarah J. Goodlin, Patient-Centered Education and Research, 681 East 17th Avenue, Salt Lake City, Utah 84103 (Email: sjg-pcer{at}comcast.net).

Symptoms and compromised quality of life prevail throughout the course of heart failure (HF) and thus should be specifically addressed with palliative measures. Palliative care for HF should be integrated into comprehensive HF care, just as evidence-based HF care should be included in end-of-life care for HF patients. The neurohormonal and catabolic derangements in HF are at the base of HF symptoms. A complex set of abnormalities can be addressed with a variety of interventions, including evidence-based HF care, specific exercise, opioids, treatment of sleep-disordered breathing, and interventions to address patient and family perceptions of control over their illness. Both potential sudden cardiac death and generally shortened length of life by HF should be acknowledged and planned for. Strategies to negotiate communication about prognosis with HF patients and their families can be integrated into care. Additional evidence is needed to direct care at the end of life, including use of HF medications, and to define management of multiple sources of distress for HF patients and their families.

Key Words: end of life • palliative care • symptom management • heart failure

Abbreviations and Acronyms
  CPAP = continuous positive airway pressure
  ESAS = Edmonton Symptom Assessment System
  HF = heart failure
  HFnEF = heart failure with normal ejection fraction
  LVSD = left ventricular systolic dysfunction
  NYHA = New York Heart Association
  SCD = sudden cardiac death
  SSRI = selective serotonin reuptake inhibitor


Related Article

Inside This Issue
J. Am. Coll. Cardiol. 2009 54: A26. [Full Text] [PDF]





 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement